Expanded Materials and Methods

Cell lines and primary cultures
The Jurkat (T cell lymphoblast-like) cell line was cultured in RPMI 1640 supplemented with 10% heat inactivated fetal calf serum (FCS), 2 mM L-glutamine, 100 U/mL penicillin and 25 μg/mL gentamycin.
Human umbilical vein endothelial cells (HUVECs), and human aortic endothelial cells (HAECs) (Lonza, Walkersville, USA) were grown on gelatin (Sigma) coated wells using EBM-2 medium, supplemented with EGM-2 SingleQuots (Lonza) and 10% FCS. Umbilical artery smooth muscle cells (UASMCs; Lonza) were grown in SmGM2 bullet kit medium (Lonza), supplemented with 10% FCS.
Experiments with these primary cells were carried out at passages 4-8. Among endothelial progenitor cells (EPCs), endothelial colony-forming cells (ECFCs) exhibit features of a true endothelial progenitor population [1, 2] . ECFCs were isolated as described [3] and were grown on gelatin coated wells using EBM-2 medium, supplemented by 20% FCS and by EGM-2 SingleQuots (Lonza). ECFCs are able to form the endothelial lining of blood vessels when subcutaneously injected in combination with smooth muscle cells or bone marrow-derived mesenchymal progenitor cells (bmMPCs) in mice [4, 5] bmMPCs were grown on fibronectin (Millipore) coated wells using EBM-2 medium, supplemented by 20% FCS and by rhFGF-B, R3-IGF-1, ascorbic acid, and GA-1000 (Lonza). bmMPCs were differentiated into pericytes by seeding bmMPCs together with ECFCs at a ratio 1:1 at a total density of 10 4 cells/cm 2 on fibronectin-coated plates in EBM-2 medium containing 20% FCS. All cell types were cultured in a 5%
CO 2 atmosphere at 37ºC. For in vitro wound healing assays, cells were grown to confluence and multiple wounds were created by scratching the cell monolayer using a sterile pipette tip. Plates were immediately washed with PBS to remove the remaining cells and fresh medium was added. Cells were photographed and collected at the times indicated, and analyzed for endoglin expression by immunofluorescence flow cytometry.
Expression and silencing vectors and cell transfections
The expression vector encoding HA-tagged full length endoglin (Endo-FL; amino acids 26-658) and the derived truncated construct 437/586-Endo (amino acids 437-586) in pDisplay (Invitrogen) have been previously reported [6] . The pCEXV-EndoL plasmid, encoding human L-endoglin [7] , was used to derive by PCR amplification a truncated endoglin construct containing the Zona Pellucida domain (ZPD; amino acids 340-658). The oligonucleotides used to prime the PCR synthesis of the endoglin fragment were as follows: ZPD-Endo (amino acids 340-658), 5´-GCATAGATCTCCGATCCAGACCACTC-3´ (forward) and 5´-ATACCGCGGCTATGCCATGC-3´
(reverse). The oligonucleotides were designed to introduce a BglII restriction site at the 5´-end and a
SacII site at the 3´-end and the PCR fragment was inserted into the BglII/SacII sites of pDisplay. The resulting ZPD-Endo-pDisplay vector was used to generate a mutant of the RGD motif where the Asp401 residue is replaced by Ala. Site directed mutagenesis was performed using 5´-GGACAGGGGTGCCAAGTTTGTCT-3´ (forward) and 5´-AGACAAACTTGGCACCCCTGTCC-3´
(reverse) leading to the ZPD-Endo-RGA-pDisplay vector. All endoglin constructs expressed from pDisplay contain the influenza hemagglutinin epitope HA at the NH 2 terminus. To silence endoglin expression, siRNAs (s4677 and s4679) and scrambled siRNAs (AM4611 and AM4613), as negative controls (Ambion, Life Technology), were used. Nucleofections with expression and silencing vectors were performed following the manufacturer's instructions with Amaxa nucleofector kits VCA-1003 (Jurkat cell line), VPB-1002 (HUVECs), and VPI-1004 (UASMCs) from Lonza using the Nucleofector I (AMAXA, Germany). Silencing experiments were carried out by simultaneously nucleofecting two endoglin siRNAs (s4677 and s4679) using scrambled siRNAs #1 (AM4611) and #2 (AM4613), as negative controls. Alternatively, silencing of endoglin was performed using endoglin siRNA (sc-35302; Santa Cruz Biotech) and scrambled siRNA (AllStars; Qiagen #1027280), as a negative control, in the presence of PrimeFect siRNA transfection reagent and PrimeFect diluent (PA3269 and PA3271; Lonza). Silencing of β1 integrin was performed using β1 integrin siRNA (sc-35674; Santa Cruz Biotech) and scrambled siRNA (AllStars; Qiagen #1027280), as a negative control, in the presence of PrimeFect siRNA transfection reagent and PrimeFect diluent (PA3269 and PA3271; Lonza). To monitor the suppression efficiency, immunofluorescence flow cytometry to detect endoglin or β1
integrin expression was performed on all cell types. Samples were also analyzed by confocal microscopy (Confocal Laser Scanning Microscope, CLSM, Leica TCS SP5).
Antibodies and other reagents
The following antibodies were used: Rabbit polyclonal anti-human endoglin (clone H-300, sc-20632; 
Immunofluorescence of 2D co-culture
Culture chamber slides (Millicell EZ slide, 8 well glass, Millipore #PEZGS0816, Millipore Ireland Ltd., Cork, Ireland) were coated with fibronectin and seeded with ECFC and bmMPC at a 1:1 ratio. After in vitro co-culture for seven days, bmMPC differentiate into VSMC/pericytes, as evidenced by the positivity with antibodies specific for αSMA, PDGFRβ, NG2, calponinI and Sm22α [4] . Once differentiated, cells were fixed with cold pure methanol on ice for 10 min. and washed twice with PBS. When required, UASMCs or HAECs were preincubated with 100ng/mL CXCL12 for 30 min at 37ºC, prior to CSFE labeling and cell adhesion assays. The concentrations of cycloheximide and monensin were selected from an initial dose-dependent study to exclude possible toxic effects of the drugs.
Phosphorylation and Western blot studies
Individual and combined cultures of UASMCs and HAECs were incubated in the absence or presence of 1μg/mL SolEng. At different time points, adherent cells were lysed in modified RIPA buffer (1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 50 mM HEPES, 10% glycerol, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA, 1 mM NaVO 3 , 100 mM Na 4 P 2 O 7 , 100 mM NaF, 10 μg/ml aprotinin and 5 μg/ml leupeptin, pH 7.4). The lysates were then clarified by centrifugation at 15,000 g for 10 minutes at 
Mice and in vivo assays
For Matrigel plug assays, ECFCs and bmMPCs (1:1 ratio; total cells 3x10 
Cell quantification and statistical analysis
Binding of UASMCs to HUVECs in angiogenesis assays was quantified by measuring the intensity profile using fluorescence confocal microscopy (SP5, Leica). Fluorescence images were transformed in binary system by ImageJ to quantify the percentage of cell adhesion. In adhesion assays, bound fluorescently labeled cells were lysed and quantification was carried out using a Varioskan plate reader.
All values are expressed as mean ± standard deviation. Results are representative of, at least, 5 independent experiments in triplicate samples. Statistical analysis was performed using a one-way ANOVA and Bonferroni post-test. A value of p<0.05 (*) was considered statistically significant and a value of p<0.005 (**) or p<0.001 (***) was considered statistically highly significant. Sol.Eng+ WT
